AstraZeneca is a multinational pharmaceutical company headquartered in the United Kingdom. The company operates in the Large Pharma sector and is known for its innovative medicines and treatments for various diseases. AstraZeneca has a global presence and operates in more than 100 countries worldwide. The company is committed to sustainability and has set ambitious targets to reduce its carbon footprint and transition to renewable energy sources.

Decarbonisation is a key focus area for AstraZeneca, and the company has set a target to achieve net-zero carbon emissions across its entire value chain by 2030. To achieve this goal, the company is implementing a range of measures to reduce its carbon footprint, including energy efficiency improvements, renewable energy sourcing, and the use of low-carbon technologies.

Corporate energy is another important area for AstraZeneca, and the company is committed to reducing its energy consumption and transitioning to renewable energy sources. AstraZeneca has set a target to source 100% of its electricity from renewable sources by 2025 and has already made significant progress towards this goal. The company has signed several corporate power purchase agreements (PPAs) with renewable energy developers to secure long-term, low-cost renewable energy supply.

Corporate PPAs are a key part of AstraZeneca's renewable energy strategy, and the company has signed several agreements with renewable energy developers to purchase renewable energy directly from them. These agreements allow AstraZeneca to secure long-term, low-cost renewable energy supply and reduce its carbon footprint. The company has signed PPAs for wind and solar energy projects in the United States, Spain, and Sweden, among others.

Renewable energy is a key focus area for AstraZeneca, and the company is committed to sourcing 100% of its electricity from renewable sources by 2025. The company has made significant progress towards this goal and is already sourcing a significant portion of its electricity from renewable sources. AstraZeneca has installed solar panels at several of its sites worldwide and has signed several corporate PPAs with renewable energy developers to secure long-term, low-cost renewable energy supply.

In addition to renewable energy sourcing, AstraZeneca is also implementing a range of energy efficiency measures to reduce its energy consumption and carbon footprint. The company has implemented energy management systems at several of its sites worldwide and has invested in energy-efficient technologies such as LED lighting and HVAC systems.

Overall, AstraZeneca is a leading pharmaceutical company that is committed to sustainability and decarbonisation. The company has set ambitious targets to reduce its carbon footprint and transition to renewable energy sources, and is implementing a range of measures to achieve these goals. AstraZeneca's focus on corporate energy and corporate PPAs is helping the company to secure long-term, low-cost renewable energy supply and reduce its carbon footprint, while its investment in energy efficiency measures is helping to reduce its energy consumption and carbon emissions.